Leo Pharma: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
No edit summary |
||
| Line 36: | Line 36: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | <gallery> | ||
File:Leo_Pharma_logo.svg|Leo Pharma logo | File:Leo_Pharma_logo.svg|Leo Pharma logo | ||
</gallery> | </gallery> | ||
Latest revision as of 00:34, 17 March 2025
Leo Pharma is a global pharmaceutical company specializing in dermatology and critical care. Founded in 1908, it is headquartered in Ballup, Denmark. The company's primary focus is on developing, manufacturing, and marketing pharmaceutical drugs to dermatologic and critical care patients worldwide.
History[edit]
Leo Pharma was established in 1908 by pharmacists August Kongsted and Anton Antons. The company was initially a small pharmacy in Copenhagen, but it quickly grew into a large-scale pharmaceutical manufacturer. In the early years, Leo Pharma focused on producing insulin and heparin. Over the years, the company expanded its product portfolio to include treatments for psoriasis, eczema, and other skin conditions.
Products[edit]
Leo Pharma's product portfolio includes treatments for a variety of skin conditions, including psoriasis, eczema, actinic keratosis, and skin infections. Some of the company's most well-known products include Dovonex, Fucidin, and Innohep.
Dovonex[edit]
Dovonex is a topical cream used to treat psoriasis. It contains the active ingredient calcipotriol, a vitamin D3 derivative that helps to slow the overproduction of skin cells.
Fucidin[edit]
Fucidin is an antibiotic cream used to treat skin infections. It contains the active ingredient fusidic acid, which works by killing bacteria that cause infections.
Innohep[edit]
Innohep is an injectable anticoagulant used to prevent and treat blood clots. It contains the active ingredient tinzaparin, a low molecular weight heparin.
Research and Development[edit]
Leo Pharma is committed to advancing dermatology through extensive research and development. The company invests heavily in R&D, with a focus on developing innovative treatments for skin conditions. Leo Pharma's R&D efforts are guided by a patient-centric approach, aiming to improve the quality of life for people with skin conditions.
Corporate Social Responsibility[edit]
Leo Pharma is committed to corporate social responsibility (CSR). The company's CSR initiatives focus on improving access to healthcare, promoting responsible business practices, and supporting local communities. Leo Pharma's CSR efforts are guided by the United Nations' Sustainable Development Goals.
See Also[edit]
References[edit]
<references />
-
Leo Pharma logo
